
Infermedica raises $30 M in Series B funding
We’re proud to announce another landmark occasion that enables Infermedica’s growth on a mission for better healthcare.
We’re proud to announce another landmark occasion that enables Infermedica’s growth on a mission for better healthcare.
A roundup of what we’ve accomplished in 2021, and what’s to come next year from Infermedica’s CEO, Piotr Orzechowski.
Discover what happened at Infermedica in the past months and how it led us to support global healthcare despite the challenges of 2020.
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.